慢性阻塞性肺疾病(COPD)的治疗效果因长效型支气管扩张剂的上市而有很大改善。为改善COPD的气短,减少肺容量很重要。吸入激素的普及显著减少了哮喘死亡。作为哮喘气道炎症的监测,呼出气凝集液的检查很受重视。肺癌分子靶向药物效果预测因子的研究有了进展。特发性间质性肺炎中,特发性肺纤维化发生频率最高且预后不良。 Therapeutic efficacy of chronic obstructive pulmonary disease (COPD) is greatly improved by the availability of long-acting bronchodilators. In order to improve COPD shortness of breath, it is important to reduce lung volume. The popularity of inhaled hormones significantly reduced asthma deaths. As the monitoring of airway inflammation in asthma, exhaled air condensate examination is valued. Progress has been made in the study of molecular predictors of lung cancer-targeted drug effects. Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis, the highest frequency and poor prognosis.